JP2013501031A5 - - Google Patents

Download PDF

Info

Publication number
JP2013501031A5
JP2013501031A5 JP2012523342A JP2012523342A JP2013501031A5 JP 2013501031 A5 JP2013501031 A5 JP 2013501031A5 JP 2012523342 A JP2012523342 A JP 2012523342A JP 2012523342 A JP2012523342 A JP 2012523342A JP 2013501031 A5 JP2013501031 A5 JP 2013501031A5
Authority
JP
Japan
Prior art keywords
methyl
oxo
phenoxy
pyridazin
trifluoromethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012523342A
Other languages
English (en)
Japanese (ja)
Other versions
JP5901520B2 (ja
JP2013501031A (ja
Filing date
Publication date
Priority claimed from FR0955504A external-priority patent/FR2948939B1/fr
Application filed filed Critical
Publication of JP2013501031A publication Critical patent/JP2013501031A/ja
Publication of JP2013501031A5 publication Critical patent/JP2013501031A5/ja
Application granted granted Critical
Publication of JP5901520B2 publication Critical patent/JP5901520B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012523342A 2009-08-05 2010-08-05 2hピリダジン−3−オン誘導体、その製造、およびそれらのscd−1インヒビターとしての使用 Expired - Fee Related JP5901520B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0955504A FR2948939B1 (fr) 2009-08-05 2009-08-05 Derives de 2h pyridazin-3-ones, leur preparation et leur application en therapeutique humaine
FR0955504 2009-08-05
PCT/EP2010/061426 WO2011015629A1 (en) 2009-08-05 2010-08-05 Derivatives of 2h pyridazin- 3 -ones, their preparation and their use as scd-1 inhibitors

Publications (3)

Publication Number Publication Date
JP2013501031A JP2013501031A (ja) 2013-01-10
JP2013501031A5 true JP2013501031A5 (enExample) 2013-09-12
JP5901520B2 JP5901520B2 (ja) 2016-04-13

Family

ID=41582079

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012523342A Expired - Fee Related JP5901520B2 (ja) 2009-08-05 2010-08-05 2hピリダジン−3−オン誘導体、その製造、およびそれらのscd−1インヒビターとしての使用

Country Status (10)

Country Link
US (1) US8946225B2 (enExample)
EP (1) EP2462121B1 (enExample)
JP (1) JP5901520B2 (enExample)
AR (1) AR077715A1 (enExample)
ES (1) ES2536841T3 (enExample)
FR (1) FR2948939B1 (enExample)
HU (1) HUE025513T2 (enExample)
PL (1) PL2462121T3 (enExample)
TW (1) TW201109313A (enExample)
WO (1) WO2011015629A1 (enExample)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR086113A1 (es) 2011-04-30 2013-11-20 Abbott Lab Isoxazolinas como agentes terapeuticos
JP6254087B2 (ja) * 2011-10-15 2017-12-27 ジェネンテック, インコーポレイテッド 癌を治療するためのscd1アンタゴニスト
US9238658B2 (en) 2011-12-06 2016-01-19 Janssen Pharmaceutica Nv Substituted piperidinyl-carboxamide derivatives useful as SCD 1 inhibitors
WO2013085957A1 (en) * 2011-12-06 2013-06-13 Janssen Pharmaceutica Nv Substituted piperidinyl-pyridazinyl derivatives useful as scd 1 inhibitors
SG10202008963QA (en) 2015-09-18 2020-10-29 Univ Miyazaki Long-acting adrenomedullin derivative
CN110099898B (zh) 2016-10-24 2023-07-25 优曼尼蒂治疗公司 化合物及其用途
KR20190108118A (ko) 2017-01-06 2019-09-23 유마니티 테라퓨틱스, 인크. 신경계 장애의 치료를 위한 방법
EP3700934A4 (en) 2017-10-24 2021-10-27 Yumanity Therapeutics, Inc. COMPOUNDS AND USES OF THESE COMPOUNDS
BR112020019191A2 (pt) 2018-03-23 2021-01-05 Yumanity Therapeutics, Inc. Compostos e seus usos
EP3914593A4 (en) * 2019-01-24 2022-11-02 Yumanity Therapeutics, Inc. CONNECTIONS AND USES THEREOF
EA202192047A1 (ru) 2019-11-13 2021-12-08 Юманити Терапьютикс, Инк. Соединения и их применение

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060037410A (ko) * 2003-07-30 2006-05-03 제논 파마슈티칼스 인크. 피리다진 유도체 및 그의 치료제로서의 용도
US7759348B2 (en) 2003-07-30 2010-07-20 Xenon Pharmaceuticals Inc. Pyridazine derivatives and their use as therapeutic agents
RU2339381C2 (ru) * 2004-02-09 2008-11-27 Ниссан Кемикал Индастриз, Лтд. Ингибитор гиперплазии интимы сосудов
AU2006326815A1 (en) * 2005-12-20 2007-06-28 Merck Frosst Canada Ltd. Heteroaromatic compounds as inhibitors of stearoyl-coenzyme A delta-9 desaturase
JP4984701B2 (ja) * 2006-07-18 2012-07-25 富士ゼロックス株式会社 Ledプリントヘッドの製造方法
JP4695565B2 (ja) * 2006-08-21 2011-06-08 株式会社リコー 画像形成装置
EP2065369A4 (en) * 2006-08-23 2011-12-28 Astellas Pharma Inc UREA CONNECTION OR SALT THEREOF
WO2008044767A1 (en) * 2006-10-13 2008-04-17 Takeda Pharmaceutical Company Limited Aromatic amine derivative and use thereof
EP2173711B1 (en) 2007-08-08 2010-11-17 Graceway Pharmaceuticals, LLC Phenoxy-pyrrolidine derivative and its use and compositions

Similar Documents

Publication Publication Date Title
JP2013501031A5 (enExample)
CN103274961B (zh) 治疗细胞增殖紊乱的化合物和方法
KR101593708B1 (ko) 항섬유증 제제의 할로겐화 유사체
KR102806160B1 (ko) 신규 3,5-이치환 피리딘 및 3,5-이치환 피리다진 유도체 및 그의 의약 용도
DK2940013T3 (en) HALOGEN-SUBSTITUTED HETEROCYCLIC COMPOUND
JP2013508306A (ja) 縮合環類似体の抗線維症剤
JP2007500720A5 (enExample)
JP4463103B2 (ja) ベンズイミダゾール誘導体およびプロトンポンプ阻害剤のプロドラッグとしてのその使用
US7449457B2 (en) Substituted heterocyclic carboxamides with antithrombotic activity
US8772327B2 (en) Phenylpropionic acid derivative and use thereof
JP2009543792A5 (enExample)
EP2274295A1 (en) 3, 4 - substituted piperidine derivatives as renin inhibitors
US8044236B2 (en) Carboxilic acid derivatives
AU2007265940A1 (en) Novel 6-5 System Bicyclic Heterocyclic Derivative And Its Pharmaceutical Utility
TW202132308A (zh) 作為5-羥基色胺受體7之調節劑之新穎官能化內酯及其使用方法
EP3719010B1 (en) Aromatic compound, pharmaceutical composition thereof and use thereof
CN118748993A (zh) 吲唑化合物和药物
EP1644334B1 (en) Antithrombotic ethers
US12503460B2 (en) Matrix metalloproteinase (MMP) inhibitors and methods of use thereof
US20070010564A1 (en) Heteroarylethenyl derivatives, their manufacture and use as pharmaceutical agents
CN105263926A (zh) 苯并噻吩化合物
MX2007007910A (en) Compositions and methods of treating cell proliferation disorders
HK1188985B (en) Compositions and methods of treating cell proliferation disorders
HK1108695B (en) Compositions and methods of treating cell proliferation disorders